Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.09.2021 | Case report

Bendamustine/obinutuzumab

COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Drouin AC, et al. Successful clearance of 300 day sars-cov-2 infection in a subject with b-cell depletion associated prolonged (B-deap) covid by regen-cov anti-spike monoclonal antibody cocktail. Viruses 13: No. 7, 23 Jun 2021. Available from: URL: http://doi.org/10.3390/v13071202 Drouin AC, et al. Successful clearance of 300 day sars-cov-2 infection in a subject with b-cell depletion associated prolonged (B-deap) covid by regen-cov anti-spike monoclonal antibody cocktail. Viruses 13: No. 7, 23 Jun 2021. Available from: URL: http://​doi.​org/​10.​3390/​v13071202
Metadaten
Titel
Bendamustine/obinutuzumab
COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report
Publikationsdatum
01.09.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-02017-2

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Hyaluronic acid

Case report

Multiple drugs

Case report

Multiple drugs